Health
Study: Hydroxychloroquine plus azithromycin linked to significant cardiovascular risks – News-Medical.Net
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
Reviewed by Emily Henderson, B.Sc.Aug 25 2020
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM. This network study, led by the Observational Health Data Sciences and Informatics community, was recently published in Lancet Rheumatology.
OHDSI has established an international network of researchers and observational health databases with a…
-
Noosa News16 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News22 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business21 hours agoAre BHP shares are buy after its results?
-
Business12 hours agoWhere next for the CBA share price?